Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and Pyrosequencing
Targeted therapies and, more precisely, <i>EGFR</i> tyrosine kinase inhibitors (TKIs) have been a major improvement in the therapeutic management of <i>EGFR</i>-mutated non-small-cell lung cancers (NSCLCs). Earlier administration of these TKIs throughout tumor progression is...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/10/8/527 |